Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)

NCT05247125 is registered in ClinicalTrials.gov with Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health as lead sponsor.

NCT NCT05247125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Interventional)
Lead sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Phase
Phase 4
Overall status
Recruiting
Start date
March 1, 2022
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, acute, sleep disorders, circadian rhythm